Outcomes of Veno Arterial ECMO
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Dec 13, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effectiveness of veno-arterial extracorporeal membrane oxygenation (VA ECMO), a special type of life-support treatment used for patients who are experiencing severe heart problems, such as cardiac arrest or very low blood pressure. The goal of the study is to understand better how this treatment can help improve survival rates, as currently, only about 40% of patients survive to leave the hospital after being treated with VA ECMO.
To participate in this trial, individuals must be at least 18 years old and currently receiving VA ECMO treatment. The trial is open to all genders. If eligible, participants can expect to be monitored closely while receiving this life-saving therapy, and their health outcomes will be tracked to see how effective VA ECMO is in improving survival rates. This research is being conducted at Amiens hospital university, a center that specializes in this type of care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age : ≥ 18
- • Patient with a VA ECMO
- Exclusion Criteria:
- • age\<18
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials